06 February 2017
Byotrol plc
("Byotrol" or the "Company")
Director Dealing
Byotrol plc, the specialist anti-microbial technology company, is pleased to announce that on 03 February 2016 John Langlands, Chairman of the Company has purchased 800,000 ordinary shares of 0.25p each ("Ordinary Shares") at a price of 4.195p per Ordinary Share (the "Purchase"). Following the Purchase, Mr. Langlands has an interest in 1,100,000 Ordinary Shares representing 0.41% of the total voting rights of the Company.
Enquiries:
Byotrol plc |
01925 742 000 |
David Traynor - Chief Executive
|
|
finnCap Ltd |
020 7220 0500 |
(Nominated Adviser & Broker) |
|
Geoff Nash/Carl Holmes/James Thompson - Corporate Finance |
|
Mia Gardner - Corporate Broking |
|
|
|
The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.
Notes to Editors:
Byotrol plc (BYOT.L), quoted on AIM, is a specialist in developing, formulating and commercialising cutting-edge antimicrobial technologies.
Our patented suite of technologies delivers powerful broad-spectrum efficacy with residual performance optimised against commonly occurring and industry-specific pathogens
Founded in 2005, the Company has developed the technology that creates easier, safer and cleaner lives.
For more information, please go to www.byotrol.co.uk
1. |
Details of the person discharging managerial responsibilities / person closely associated |
|||||||
a) |
Name |
John Langlands |
||||||
2. |
Reason for the Notification |
|||||||
a) |
Position/status |
Chairman |
||||||
b) |
Initial notification/Amendment |
Initial |
||||||
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||
a) |
Name |
Byotrol Plc |
||||||
b) |
LEI |
N/A |
||||||
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||
a) |
Description of the Financial instrument, type of instrument |
ordinary shares of 0.25p each |
||||||
Identification code |
GB00B0999995 |
|||||||
b) |
Nature of the transaction |
Purchase of Ordinary Shares |
||||||
c) |
Price(s) and volume(s) |
|
||||||
d) |
Aggregated information: · Aggregated volume · Price |
800,000 ordinary shares of 0.25p each purchased at 4.195p per ordinary share |
||||||
e) |
Date of the transaction |
03 February 2017 |
||||||
f) |
Place of the transaction |
London Stock Exchange, AIM Market (XLON) |